<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02705222</url>
  </required_header>
  <id_info>
    <org_study_id>SMM</org_study_id>
    <nct_id>NCT02705222</nct_id>
  </id_info>
  <brief_title>Comparison Between D&amp;C and Hysteroscopy in Management of AUB in Perimenopausal Women</brief_title>
  <official_title>Comparison Between Dilatation and Curettage and Hysteroscopy in Management of Abnormal Uterine Bleeding in Perimenopausal Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mohamed Sayed Abdelhafez</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare dilatation and curettage with hysteroscopy in obtaining
      an accurate diagnosis of the etiology of abnormal uterine bleeding and outlining a mode of
      treatment-specific to the cause.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Perimenopausal women complaining of abnormal uterine bleeding will be selected for assessment
      through detailed history taking, general and abdominal examination, local gynecological
      examination, transvaginal sonography (TVS) scanning and routine blood investigations.
      Eligible participants in our study will be those who complain of menorrhagia, metrorrhagia,
      polymenorrhoea or polymenorrhagia without local gynecological cause with failure of medical
      treatment for at least 3 months. All women participating in the study will be randomly
      allocated into two groups; dilatation and curettage (D&amp;C) group and hysteroscopy group. For
      women in the D&amp;C group, cervical dilatation and fractional endometrial curettage will be done
      under total intravenous (IV) anesthesia in operation theater and the curetting will be sent
      for histopathological examination. For women in the hysteroscopy group, hysteroscopy will be
      done under total IV anesthesia in operation theater hysteroscopic-guided curettings will also
      be taken and sent for histopathological examination.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2016</start_date>
  <completion_date type="Anticipated">July 2017</completion_date>
  <primary_completion_date type="Anticipated">July 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of abnormal endometrial patterns</measure>
    <time_frame>One week after the procedure</time_frame>
    <description>Number of patients diagnosed to have abnormal endometrial patterns after histopathological examination of the curretings per total number of patients underwent the procedure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improvement rate</measure>
    <time_frame>3 months after the procedure</time_frame>
    <description>Number of patients improved after performing the procedure and recieving the treatment-specific to cause per total number of patients underwent the procedure</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Uterine Bleeding</condition>
  <arm_group>
    <arm_group_label>D&amp;C group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Women will undergo D&amp;C</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hysteroscopy group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Women will undergo hysteroscopy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>D&amp;C</intervention_name>
    <description>Cervical dilatation and fractional endometrial curettage will be done in operation theatre and the curetting will be sent for histopathological examination</description>
    <arm_group_label>D&amp;C group</arm_group_label>
    <other_name>Dilatation and curettage</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hysteroscopy</intervention_name>
    <description>Hysteroscopy will be done in operation theatre and hysteroscopic-guided curettings will also be taken and sent for histopathological examination</description>
    <arm_group_label>Hysteroscopy group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Perimenopausal women complaining of abnormal uterine bleeding (menorrhagia,
             metrorrhagia, polymenorrhoea or polymenorrhagia) without local gynecological cause.

          -  Failure of medical treatment for at least 3 months.

        Exclusion Criteria:

          -  Age &lt; 45 or &gt; 55 years.

          -  Blood disorders or coagulopathy.

          -  Diagnosed or suspected local gynecologic lesion (polyp, adenomyosis, myoma, malignancy
             or cervical pathology).

          -  Use intrauterine contraceptive device.

          -  Pregnancy related conditions.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sara M Madany</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mansoura University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohamed S Abdelhafez, Dr</last_name>
    <role>Study Director</role>
    <affiliation>Mansoura University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Moustafa H Nawwar, Dr</last_name>
    <role>Study Director</role>
    <affiliation>Mansoura University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohamed A Elnegeri, Prof</last_name>
    <role>Study Chair</role>
    <affiliation>Mansoura University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sara M Madany</last_name>
    <email>Sarahmadany20@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Obstetrics and Gynecology Department in Mansoura University Hospital</name>
      <address>
        <city>Mansoura</city>
        <state>Dakahlia</state>
        <zip>35111</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 26, 2016</study_first_submitted>
  <study_first_submitted_qc>March 4, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 10, 2016</study_first_posted>
  <last_update_submitted>May 8, 2017</last_update_submitted>
  <last_update_submitted_qc>May 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Mohamed Sayed Abdelhafez</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>Abnormal uterine bleeding</keyword>
  <keyword>Dilatation and curettage</keyword>
  <keyword>Hysteroscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Uterine Hemorrhage</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

